Company Performance Metrics
Prevnos is a biotechnology company operating within the in vitro diagnostics sector. Prevnos engages within the cancer genetics and cytogenetics space, creating novel fluorescence in situ hybridization (FISH) assays for clinical and research use. As the inventors of the world's first Hybrid Fusion FISH™ tests for cancer genetics and
diagnostics, Prevnos enables 90%+ efficiency in FISH testing while reducing the overall economic burden for such tests. Prevnos is also the inventor of the Retina Microscope™, the world's most economical and first fluorescence scope to use transparent OLED displays and foil-glass projection displays operating through a thin-client PC, conveniently and optimally suited for a FISH dark room. It is the first FISH scope in its class.
